Department of Cardiovascular Medicine (H. Kaneko, H.I., H. Kiriyama, T.K., K.F., N.T., H.M., I.K.), University of Tokyo, Japan.
Department of Advanced Cardiology (H. Kaneko, K.F.), University of Tokyo, Japan.
Circulation. 2021 Jun 8;143(23):2244-2253. doi: 10.1161/CIRCULATIONAHA.120.052624. Epub 2021 Apr 22.
Heart failure (HF) and atrial fibrillation (AF) are growing in prevalence worldwide. Few studies have assessed to what extent stage 1 hypertension in the 2017 American College of Cardiology/American Heart Association blood pressure (BP) guidelines is associated with incident HF and AF.
Analyses were conducted with a nationwide health claims database collected in the JMDC Claims Database between 2005 and 2018 (n=2 196 437; mean age, 44.0±10.9 years; 58.4% men). No participants were taking antihypertensive medication or had a known history of cardiovascular disease. Each participant was categorized as having normal BP (systolic BP <120 mm Hg and diastolic BP <80 mm Hg; n=1 155 885), elevated BP (systolic BP 120-129 mm Hg and diastolic BP <80 mm Hg; n=337 390), stage 1 hypertension (systolic BP 130-139 mm Hg or diastolic BP 80-89 mm Hg; n=459 820), or stage 2 hypertension (systolic BP ≥140 mm Hg or diastolic BP ≥90 mm Hg; n=243 342). Using Cox proportional hazards models, we identified associations between BP groups and HF/AF events. We also calculated the population attributable fractions to estimate the proportion of HF and AF events that would be preventable if participants with stage 1 and stage 2 hypertension were to have normal BP.
Over a mean follow-up of 1112±854 days, 28 056 incident HF and 7774 incident AF events occurred. After multivariable adjustment, hazard ratios for HF and AF events were 1.10 (95% CI, 1.05-1.15) and 1.07 (95% CI, 0.99-1.17), respectively, for elevated BP; 1.30 (95% CI, 1.26-1.35) and 1.21 (95% CI, 1.13-1.29), respectively, for stage 1 hypertension; and 2.05 (95% CI, 1.97-2.13) and 1.52 (95% CI, 1.41-1.64), respectively, for stage 2 hypertension versus normal BP. Population attributable fractions for HF associated with stage 1 and stage 2 hypertension were 23.2% (95% CI, 20.3%-26.0%) and 51.2% (95% CI, 49.2%-53.1%), respectively. The population attributable fractions for AF associated with stage 1 and stage 2 hypertension were 17.4% (95% CI, 11.5%-22.9%) and 34.3% (95% CI, 29.1%-39.2%), respectively.
Both stage 1 hypertension and stage 2 hypertension were associated with a greater incidence of HF and AF in the general population. The American College of Cardiology/American Heart Association BP classification system may help identify adults at higher risk for HF and AF events.
心力衰竭(HF)和心房颤动(AF)在全球范围内的患病率不断上升。很少有研究评估 2017 年美国心脏病学会/美国心脏协会血压(BP)指南中的 1 期高血压在多大程度上与 HF 和 AF 事件的发生相关。
利用 2005 年至 2018 年在 JMDC 理赔数据库中收集的全国性健康理赔数据库进行分析(n=2196437;平均年龄 44.0±10.9 岁;58.4%为男性)。没有参与者服用抗高血压药物或有已知的心血管疾病史。每位参与者均分为正常血压(收缩压<120mmHg,舒张压<80mmHg;n=1155885)、高血压(收缩压 120-129mmHg,舒张压<80mmHg;n=337390)、1 期高血压(收缩压 130-139mmHg 或舒张压 80-89mmHg;n=459820)或 2 期高血压(收缩压≥140mmHg 或舒张压≥90mmHg;n=243342)。使用 Cox 比例风险模型,我们确定了 BP 组与 HF/AF 事件之间的关联。我们还计算了人群归因分数,以估计如果 1 期和 2 期高血压患者的血压恢复正常,HF 和 AF 事件中可预防的比例。
平均随访 1112±854 天后,发生了 28056 例 HF 和 7774 例 AF 事件。经过多变量调整后,HF 和 AF 事件的风险比分别为 1.10(95%CI,1.05-1.15)和 1.07(95%CI,0.99-1.17),分别为升高的 BP;1.30(95%CI,1.26-1.35)和 1.21(95%CI,1.13-1.29),分别为 1 期高血压;2.05(95%CI,1.97-2.13)和 1.52(95%CI,1.41-1.64),分别为 2 期高血压与正常 BP。与 1 期和 2 期高血压相关的 HF 的人群归因分数分别为 23.2%(95%CI,20.3%-26.0%)和 51.2%(95%CI,49.2%-53.1%)。与 1 期和 2 期高血压相关的 AF 的人群归因分数分别为 17.4%(95%CI,11.5%-22.9%)和 34.3%(95%CI,29.1%-39.2%)。
1 期高血压和 2 期高血压均与普通人群 HF 和 AF 的发生率增加有关。美国心脏病学会/美国心脏协会 BP 分类系统可能有助于识别 HF 和 AF 事件风险较高的成年人。